Connect with us

Houston Rockets

Terrence Jones appears unlikely to be ready anytime soon

As missed games continue to pile up for the Rockets forward, Terrence Jones’ mysterious injury threatens to keep him out even longer

Published

on

Terrence Jones

The initially not-serious leg injury to Terrence Jones continues to grow more mysterious by the day, with the forward’s absence now at eight games — over two weeks of real time — and counting.

Consider the timeline:

Nov. 3: Jones plays 30 minutes in a 104-93 win in Philadelphia but at much below his usual efficiency, scoring 6 points (3-of-11 FG) and grabbing 4 rebounds. Two nights earlier, Jones led the Rockets with 25 points (10-of-16 FG) and 10 rebounds in a home win over Boston.

Nov. 4: An hour before the Rockets play in Miami, the team lists Jones as out with a “bruised right leg”. Houston Chronicle beat writer Jonathan Feigen hears the injury “does not seem serious”.

Nov. 7: The Rockets update the official listing of the injury to a “Peroneal nerve contusion”, saying Jones will be out one week (same as Patrick Beverley, who was nursing a hamstring strain) and then reevaluated. This remains the last official Jones medical update from the team with a timetable.

Nov. 14: After said week, Kevin McHale says Beverley will be back “much sooner” than Jones. Beverley did, in fact, return for the next game (Nov. 16).

Nov. 17: Play-by-play announcer Bill Worrell says on the Rockets-Grizzlies telecast that the Rockets are “maybe a month or so away” from getting Jones back. If that timeline ends up accurate, meaning Jones returns Dec. 17 — his absence would be 19 games, or nearly 25% of the season.

Nov. 19: Houston’s PR team says a timetable on Jones hasn’t been set and that’s he’s being monitored regularly.

Nov. 20: In an interview with SportsTalk 790, GM Daryl Morey is asked for an update on Jones. His response, transcribed by ClutchFans user J.R.:

It’s a tough one. It came on quick, unexpected. They don’t know what triggered it. The nerve is not signaling his foot well but it’s coming back. It could come back as quick as it went. It’s longer rather than shorter. It’s gonna be awhile is what their best guess is. … They thought it could be caused by getting hit in the leg in a certain spot. The doctors are confident he’ll have a full recovery but don’t know when. If he was you or I, this would not be a big deal. He has full movement but just weaker now. Getting back to being a NBA player, that’s a much bigger difference.”

So in two-and-a-half weeks, this has progressed from “does not seem serious” to still “gonna be awhile”. Considering they’re also challenged up front by a minor knee injury to Dwight Howard and sub-standard play from Jones’ replacement Donatas Motiejunas (5.4 points on 36.7% FG, 5.1 rebounds, PER of 8.1), it’s certainly not welcome news for an already thin group of Rockets’ bigs.

From what I can tell, Morey’s comments look on point. Jones has been seen walking around Toyota Center without a noticeable limp. The issue, of course, is that he’s been in suits rather than basketball gear. His routine walking movement seems fine, but the nerve injury appears to have shut Jones down from any sort of strenuous physical activity.

As a result, the longer this goes on, the trickier it gets. Not only will Jones have to rehabilitate the leg, but he’ll also face a major challenge in regaining the peak conditioning that it typically takes players an entire training camp and preseason to attain. There’s also the issue of Jones’ game being extremely dependent on his speed and athleticism. Naturally, because of all the variables in play, a precise timetable for his return to play is becoming rather difficult.

I reached out to Will Carroll, lead writer for sports medicine at Bleacher Report, to see if he could recall any comparable injuries whose recoveries could serve as a template. Carroll referenced Carson Palmer, the starting quarterback for the Arizona Cardinals (though he’s now out for the season with a torn ACL, a different injury), as a possible analog. Though the nerve injury to Palmer was to his arm rather than his leg, the functionality of the throwing arm for an NFL quarterback would carry similar importance. Palmer, who suffered the injury on Sept. 8, was able to return on Oct. 12.

Summary: The reason no one knows a timetable is because even the Rockets themselves don’t know. The situation remainds fluid. What is clear, though, is this: the longer we go without hearing word of Jones resuming physical activity, the more concerning the situation becomes. It’s a real shame for Jones, who in his third year was off to a very encouraging start (14 points on 52% FG, 7.5 rebounds, 19.4 PER in 29 minutes) as the Rockets’ starter on the front line next to Howard.

In the meantime, starting Saturday, the 9-3 Rockets play five games in eight nights. With some luck, it seems Howard could help out that difficult stretch by returning early next week.

Jones, however, appears much further away, with no resolution on the horizon.

Houston Rockets

Poison Pill: The Impact of Recent Extensions on the Rockets’ Trade Options

Published

on

Just before the start of the regular season, the Houston Rockets signed Jalen Green to a three-year, $105.3 million extension and Alperen Sengun to a five-year, $185 million extension, locking up two key pieces of their rebuild. These extensions eliminated any meaningful salary cap room for Houston in the summer of 2025. However, since the NBA is trending away from key players changing teams via free agency (recent examples such as Paul George and the Rockets’ own Fred VanVleet notwithstanding), Rafael Stone and his team likely viewed the extensions as worth the risk.

The Rockets have positioned themselves as one of the league’s most interesting trade teams, as they boast a unique combination of good young players, premium future draft picks, and expiring salaries. But signing Green and Sengun to those extensions made trading each of those players this season significantly more difficult.

Article VII, Section 8(g) of the 2023 NBA Collective Bargaining Agreement – you know the one! – is more commonly known as the Poison Pill Provision, which relates to the trade treatment of players recently signed to rookie scale extensions. If a recently extended player is traded prior to the July 1 in which the extension kicks in, then while the player’s outgoing salary would be the same as his then current cap figure, the player’s incoming salary to the acquiring team would instead be the *average* of the player’s then current salary and all salaries during the extension. This makes any trade made under the Poison Pill Provisions exceedingly difficult.

Using Green and Sengun as examples, their respective outgoing and incoming salaries would be:

Jalen Green
Outgoing Salary for Houston: $12.5 million
Incoming Salary for Acquiring Team: $29.5 million

Alperen Sengun
Outgoing Salary for Houston: $5.4 million
Incoming Salary for Acquiring Team: $31.7 million

These vast discrepancies in outgoing and incoming salary treatment make Green and Sengun very difficult to trade, as most NBA trades must fall within salary-matching rules. While there are possible trade scenarios involving numerous players and salaries that could allow for Green or Sengun to be traded, most of those scenarios are unrealistic and/or would involve three or more teams and the expenditure of additional assets to get those additional teams to take on salaries.

The Rockets don’t seem to have much desire to move either Green or Sengun right now. However, if they do decide to move either of them, it would most likely not be until next July, when the Poison Pill Provision is no longer applicable and those players can be traded at their new extension salaries.

Continue Reading

Houston Rockets

Houston Rockets Draft Decisions: Who Will Be the #3 Pick?

Published

on

By

Houston Rockets Podcast

It’s officially NBA Draft Week!

The weeks of speculation are coming to an end as we’ve just about arrived at the 2024 NBA Draft. The Rockets hold picks #3 and #44 and could be quite active on the trade market.

Dave Hardisty and David Weiner paired up on the ClutchFans podcast to discuss the options before the Houston Rockets as they approach the June 26th NBA Draft. Is it really down to Donovan Clingan and Reed Sheppard as options? The pair also discuss trade-down options and whether Devin Carter could be intriguing to Ime Udoka. And are the Rockets a darkhorse for a Paul George trade?

The podcast premieres at 8:00am CT! Come join us!



CLUTCHFANS PODCAST: SPOTIFY | APPLE

Continue Reading

Houston Rockets

Podcast: Houston Rockets options with the #3 pick of the 2024 NBA Draft

Published

on

By

Houston Rockets 2024 NBA Draft prospects Zaccharie Risacher Stephon Castle Reed Sheppard Donovan Clingan

The offseason is now underway.

The forecast looks good for the Houston Rockets, but… there’s pressure as well this offseason because there are a handful of other West teams that might have rosier futures. Ime Udoka wants to win and win big. As we are about five weeks away from the NBA Draft, what are the Rockets looking to do this summer?

David Weiner joined Dave Hardisty on the ClutchFans podcast to discuss the Rockets shockingly landing the #3 pick and their options in this draft, including Reed Sheppard, Donovan Clingan, Zaccharie Risacher, Stephon Castle, Matas Buzelis and others. They also discuss the possibility of some big game hunting in Houston.


CLUTCHFANS PODCAST: SPOTIFY | APPLE

Continue Reading

Houston Rockets

Podcast: Steven Adams, Mikal Bridges and Trade Possibilities for the Rockets

Published

on

By

Houston Rockets Trade Deadline 2024

The Houston Rockets already made one deal, acquiring center Steven Adams from Memphis for a handful of second-round picks, but we still have several days left before this Thursday’s NBA Trade Deadline.

Are more deals on the way?

Rumors of interest in Mikal Bridges have swirled, with the Rockets holding precious (and unprotected) first-round picks from Brooklyn. They also could use some help inside this season, which Adams can not provide. Shooting is always in demand.

David Weiner joined Dave Hardisty on the ClutchFans podcast to discuss the Adams trade, its impact on the Rockets in 2024-25 and beyond, the Mikal Bridges rumors, the Brooklyn picks, other trade possibilities and options for Rafael Stone moving forward. Also discussed is the play of Houston’s core 6 prospects: Amen Thompson, Cam Whitmore, Alperen Sengun, Jabari Smith Jr., Tari Eason and Jalen Green.


CLUTCHFANS PODCAST: SPOTIFY | APPLE

Continue Reading

Houston Rockets

Rockets trade for center Steven Adams

Published

on

By

Steven Adams Houston Rockets

The Rockets made a surprise trade on Thursday, sending the contract of Victor Oladipo and three second-round picks to Memphis for center Steven Adams.

The deal came together quickly and the Rockets had a small window to get it done, hence why this trade was made with a week to go until the trade deadline.

The Price

When you consider that Memphis did this for cost savings primarily and that Adams would not play for any team in the league this season, the price seemed a little high to me. The Rockets gave up the OKC second-round pick this year, which is no big loss, but they also give up the better of Brooklyn’s or Golden State’s second-round pick this season. That’s a pretty good pick (likely in the late 30’s). They also give up the better of Houston’s or OKC’s second-round pick in 2025. If things go as planned for the Rockets, that pick should be in the 45-55 range.

But they didn’t sacrifice a first-round pick, which would have been brutal, and they were not going to use all those seconds this season. So it’s just a matter of opportunity cost — who else could they have gotten for this package?

My understanding is they (particularly Ime Udoka) are very high on Adams.

The Rockets also did this move for cap purposes as well. By moving out the Oladipo contract, which was expiring, and bringing in Adams’ deal, which is signed for $12.4M next season, the window for the Rockets to put together a trade package for a star player is extended out until the 2025 trade deadline. They continue to wait to see which players, if any, shake loose here and become available. They want flexible (see: expiring) contracts that they can combine with assets and this gives them another year to be in that position.

The Trade

It’s not often that the Rockets acquire a player I had not considered beforehand but that’s the case with Steven Adams. The Rockets sorely need a big with size that provides more traditional center strengths, making Clint Capela, Robert Williams, Nick Richards or Daniel Gafford potential candidates, but Adams was overlooked for a few reasons.

First, the 30-year old big man is out for the season after knee surgery cost him the entire 2023-24 campaign, so the Rockets won’t get any benefit from this trade this season. Secondly, Adams is not your traditional center either when it comes to rim protection.

But what Adams does do, he’s really good at and he has some of the same strengths of Brook Lopez, who the Rockets tried to sign in the offseason. Adams is quite possibly the strongest guy in the league and a legitimate 6-foot-11 with a 7-foot-5 wingspan. He’s an outstanding screen-setter, something that could really benefit the likes of Fred VanVleet, Amen Thompson and Jalen Green. He was also an elite rebounder last season, finishing 6th in the league in caroms at 11.5 a game despite playing just 27.0 minutes a contest.

After watching Jonas Valanciunas absolutely bully the Rockets inside on Wednesday, it should be apparent by now to everyone that this was a pretty big need.

In 2021-22, the Memphis Grizzlies finished #2 in the West at 56-26. Their top two players in Net Rating that season were Dillon Brooks (+11.0) and Adams (+8.3), key cogs in a defense that held opponents to 108.6 points per 100 possessions. They’re both now Houston Rockets.

So this adds another trusted vet to Ime Udoka’s rotation.

The question is will the 30-year old Adams return to form after the knee injury? Adams sprained the posterior cruciate ligament in his right knee a year ago, which cost him the end of that season and the playoffs. He tried rehabbing it and it never got better, so surgery became the option just as this season was kicking off.

I like to think the Rockets did their due diligence on that, despite the short time it took for this deal to come together, but that’s unclear.

If he does bounce back, then Udoka has a big man he can turn to reliably in situational matchups or on nights when the younger bigs struggle. He wouldn’t be Boban or even Jock Landale in that scenario — he’s going to play, so the frontcourt depth in 2024-25 should be better. In the end, they got a starting-caliber center who will have no problems coming off the bench, and that’s what they were looking for.

Continue Reading

Trending